Any thoughts on how this is going to look? Seems very strange when they already had 20 million + according to last 4c. I guess one benefit of current sp is they could raise 60 million and only issue 300 million shares which would be relatively small compared to the register size. I guess they now have a reasonable list of drugs with strong potential to make it to market? I'm assuming a capital raise is not another name for a takeover or buyout but I keep thinking the substantial holders surely would need a big buyer, not much chance of selling huge holding on market
Any thoughts on how this is going to look? Seems very strange...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.005(0.40%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.22 | $456.0K | 366.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 4690 | 3 |
View Market Depth
| Last trade - 11.43am 01/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |